Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Inflammation × Pregabalin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Pain, Postoperative 8 Pain 5 Breast Neoplasms 5 Neuralgia 4 Agnosia 4 Neoplasms 2 Head and Neck Neoplasms 2 Chronic Pain 2 Visceral Pain 1 Spinal Cord Neoplasms 1 Seizures 1 Pinealoma 1 Persistent Postoperative Pain 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Obesity 1 Neuroectodermal Tumors, Primitive 1 Myotoxicity 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Neoplasms 1 Leiomyoma 1 Inflammation 1 Hot Flashes 1 Gliosarcoma 1 Glioma 1

Interventions

Omeprazole 3 Exercise 3 salicylsalicylic acid 2 palbociclib 2 XENP 1595 2 Vitamin D 2 Tea 2 Tablets 2 Sufentanil 2 Resistance Training 2 Nutrition Assessment 2 Metformin 2 Ketorolac 2 Ibuprofen 2 Fish Oils 2 Etanercept 2 Colchicine 2 Ascorbic Acid 2 soybean oil, phospholipid emulsion 1 montelukast 1 microcrystalline cellulose 1 ginger extract 1 falcarinol 1 falcarindiol 1 epigallocatechin gallate 1 dolutegravir 1 dapagliflozin 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Sulindac 1 Spironolactone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡